JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive: It’s been previously reported that the Janus kinase 2 (JAK2)/STAT5 pathway plays a crucial role in the survival and proliferation of chronic myeloid leukemia cells obtained from patients32.